Atea Pharmaceuticals
Price & Volume
Stats
See moreOpen | $5.78 |
Previous Close | $5.71 |
Day Range | $5.77-$5.90 |
52W Range | $2.45-$6.45 |
Market Cap | $451.7M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $192.1M |
Revenue Growth (YoY) | 295.2% |
Gross Profit (12 Mos) | -$146.5M |
Diluted EPS | -$1.94 |
News
See moreYahoo Finance • 2 months ago
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
Yahoo Finance • 4 months ago
Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
Yahoo Finance • 4 months ago
Nano Dimension And 2 Other Penny Stocks With Promising Potential
Yahoo Finance • 5 months ago
Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference
About
CEO | Dr. Jean-Pierre Sommadossi Ph.D. |
CFO | Ms. Andrea J. Corcoran J.D. |
Address | 225 Franklin Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |
